Sign In
Buy SNY
$42.37
-0.430 (-1.00%)
At Close: Jun 03, 2026
Drug Startups Eye Quicker Profits Under China's New Fast-Track Approvals
02:01pm, Wednesday, 09'th Jun 2021
A recent regulatory overhaul designed to speed up development and approval of new drugs in China has been welcomed by global pharma giants and local startups alike, aimed at bringing their latest cutt
Sanofi (SNY) Management Presents on 2021 American Society of Clinical Oncology (ASCO) Annual Meeting Conference (Transcript)
03:53pm, Friday, 04'th Jun 2021
Sanofi (SNY) Management Presents on 2021 American Society of Clinical Oncology (ASCO) Annual Meeting Conference (Transcript)
Sanofi CEO on breakthroughs in cancer research, COVID-19 vaccine development, and drug pricing
01:53pm, Friday, 04'th Jun 2021
Sanofi CEO Paul Hudson joins Yahoo Finance's Anjalee Khemlani to discuss the company's cancer research, COVID-19 vaccine efforts, and drug pricing. Watch the 2021 Berkshire Hathaway Annual Shareholder
Sanofi Inks Partnership for Late-Stage Trial of Amcenestrant as Add-On Breast Cancer Therapy
10:11am, Friday, 04'th Jun 2021
Sanofi SA (NASDAQ: SNY) has secured partners for a Phase 3 trial to study amcenestrant versus the hormone therapy tamoxifen in breast cancer. The Breast International Group (BIG), the European Orga
PARIS, June 4, 2021 /PRNewswire/ -- Sanofi is partnering with leading groups delivering practice-changing breast cancer research, the Breast International Group (BIG), the European Organization for Re
7 Best Vaccine Stocks for Their Pipeline Potential
01:45pm, Thursday, 03'rd Jun 2021
These Covid-19 vaccine stocks may be late in the race, but they certainly have growth potential as we head into the summer. The post 7 Best Vaccine Stocks for Their Pipeline Potential appeared first o
White House to allow AstraZeneca, Novavax, Sanofi to distribute COVID-19 shots how they see fit
11:30am, Thursday, 03'rd Jun 2021
The White House said Thursday that it removed a requirement that is part of the Defense Production Act that gives the U.S. preferential orders for the COVID-19 vaccines developed by AstraZeneca , Nova
Sanofi's (SNY) Management on Alliance Bernstein 37th Annual Strategic Decisions Conference - Transcript
04:47pm, Wednesday, 02'nd Jun 2021
Sanofi's (SNY) Management on Alliance Bernstein 37th Annual Strategic Decisions Conference - Transcript
Top COVID-19 Vaccine Stories of May Put Biotech ETFs in Focus
04:32pm, Tuesday, 01'st Jun 2021
Let's take a look at some top coronavirus vaccine stories of May and the possible impact they can have on biotech ETFs.
Sanofi (SNY) Stops Venglustat Development as Kidney Cyst Drug
11:16am, Tuesday, 01'st Jun 2021
Sanofi (SNY) discontinues development of pipeline candidate, venglustat, in patients with autosomal dominant polycystic kidney disease, following failure in a pivotal study.
The 91 'Best Dividend Stocks On Earth' For June
10:52pm, Thursday, 27'th May 2021
Kiplinger "insights for investors" online, first offered this list of 91 "Top Dividend Stocks From Around The World" July 13, 2020. Data updated 5/25/21 revealed 13 yields ripe for picking. These Inte
Sanofi/Glaxo Initiate Pivotal Global COVID-19 Vaccine Study
09:46am, Thursday, 27'th May 2021
Sanofi (SNY) and Glaxo initiate phase III study to evaluate their adjuvanted COVID-19 vaccine candidate. A booster program will start soon.
Sanofi and GlaxoSmithKline begin Phase 3 study of COVID-19 vaccine candidate
05:59am, Thursday, 27'th May 2021
French pharmaceutical group Sanofi [s:fr: san] and U.K. drug company GlaxoSmithKline said they have begun global Phase 3 efficacy studies of their jointly produced COVID-19 candidate. The randomized,
New Covid-19 Vaccine Will Be Produced This Year As Sanofi, GSK Launch Phase 3 Trial
05:39am, Thursday, 27'th May 2021
One part of the trial will test the vaccine against the South African variant of the virus.
35 Graham Formula Value Dogs Sport 26 Ideal June Dividend Payers
01:33pm, Wednesday, 26'th May 2021
"Benjamin Graham Value Stocks match the criteria. Benjamin Graham followed." -YCharts Value Screener. These 35 Graham Formula Picks were screened by YCharts for revenue, assets, long-term debt, and EP
